Cargando…

Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease

Interleukin 33 (IL-33) that signals through the ST2 receptor has emerged as a critical modulator in several inflammatory disorders, including inflammatory bowel disease (IBD). However, the precise mechanisms by which IL-33 modulates IBD are controversial. The aim of this study was thus to clarify th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seo, Dong Hyuk, Che, Xiumei, Kwak, Min Seob, Kim, Soochan, Kim, Jae Hyeon, Ma, Hyun Woo, Kim, Da Hye, Kim, Tae Il, Kim, Won Ho, Kim, Seung Won, Cheon, Jae Hee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429815/ https://www.ncbi.nlm.nih.gov/pubmed/28404987 http://dx.doi.org/10.1038/s41598-017-00840-2

Ejemplares similares

Triggering Receptor Expressed on Myeloid Cells-1 Agonist Regulates Intestinal Inflammation via Cd177(+) Neutrophils
por: Seo, Dong Hyuk, et al.
Publicado: (2021)

The Correlation of Serum IL-12B Expression With Disease Activity in Patients With Inflammatory Bowel Disease
por: Lee, Hye Won, et al.
Publicado: (2016)

Physical activity and quality of life of patients with inflammatory bowel disease
por: Kim, Bun, et al.
Publicado: (2021)

Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease
por: Chung, Sook Hee, et al.
Publicado: (2016)

Probe-based confocal laser endomicroscopy in the differential diagnosis of inflammatory bowel diseases: a case series
por: Park, Jung Won, et al.
Publicado: (2018)

Long-Term Outcomes of Endoscopic Balloon Dilation for Benign Strictures in Patients with Inflammatory Bowel Disease
por: Lee, Hye Won, et al.
Publicado: (2018)

Melatonin controls microbiota in colitis by goblet cell differentiation and antimicrobial peptide production through Toll-like receptor 4 signalling
por: Kim, Seung Won, et al.
Publicado: (2020)

Novel Potassium-Competitive Acid Blocker, Tegoprazan, Protects Against Colitis by Improving Gut Barrier Function
por: Son, Mijeong, et al.
Publicado: (2022)

Proteomics-based functional studies reveal that galectin-3 plays a protective role in the pathogenesis of intestinal Behçet’s disease
por: Lee, Hyun Jung, et al.
Publicado: (2019)

Accuracy of three different fecal calprotectin tests in the diagnosis of inflammatory bowel disease
por: Jang, Hui Won, et al.
Publicado: (2016)

Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease
por: Kwak, Min Seob, et al.
Publicado: (2014)

Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?
por: Kim, Duk Hwan, et al.
Publicado: (2016)

The Effect of the Menstrual Cycle on Inflammatory Bowel Disease: A Prospective Study
por: Lim, Sun Min, et al.
Publicado: (2013)

Development of a Novel Endoscopic Scoring System to Predict Relapse after Surgery in Intestinal Behçet’s Disease
por: Park, Jung Won, et al.
Publicado: (2018)

Characteristics and Treatment Outcomes of Transition among Patients with Inflammatory Bowel Disease
por: Yoo, Eun Jin, et al.
Publicado: (2023)

Overlooked Management and Risk Factors for Anemia in Patients with Intestinal Behçet’s Disease in Actual Clinical Practice
por: Kim, Bun, et al.
Publicado: (2015)

Identification of genetic susceptibility loci for intestinal Behçet’s disease
por: Kim, Seung Won, et al.
Publicado: (2017)

Correlation between Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Endoscopic Activity in Intestinal Behçet's Disease
por: Lee, Hyun Jung, et al.
Publicado: (2014)

Is fasting beneficial for hospitalized patients with inflammatory bowel diseases?
por: Park, Yong Eun, et al.
Publicado: (2020)

Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
por: Park, Jihye, et al.
Publicado: (2018)

Outcome Predictors for Intestinal Behçet's Disease
por: Park, Jae Jun, et al.
Publicado: (2013)

Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behçet’s disease: folate, vitamin B12, 25-OH-vitamin D, and ferritin
por: Park, Yong Eun, et al.
Publicado: (2021)

Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model
por: Park, Jihye, et al.
Publicado: (2021)

C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet’s disease
por: Kang, Eun Ae, et al.
Publicado: (2021)

Vaccination and Complementary and Alternative Medicine in Patients with Inflammatory Bowel Disease
por: Kim, Sung Bae, et al.
Publicado: (2014)

Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer
por: Seo, Yoojeong, et al.
Publicado: (2020)

Succinate-treated macrophages attenuate dextran sodium sulfate colitis in mice
por: Park, I Seul, et al.
Publicado: (2021)

Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
por: Han, So Jung, et al.
Publicado: (2023)

Radiation Exposure from Abdominal Imaging Studies in Patients with Intestinal Behçet Disease
por: Jung, Yoon Suk, et al.
Publicado: (2014)

Production of Interleukin-2 (IL-2) and Expression of IL-2 Receptor in Patients with IgA Nephropathy
por: Lee, Tae-Won, et al.
Publicado: (1992)

Inflammatory bowel disease–associated intestinal fibrosis
por: Park, Ji Min, et al.
Publicado: (2023)

The risk of lymph node metastasis makes it unsafe to expand the conventional indications for endoscopic treatment of T1 colorectal cancer: A retrospective study of 428 patients
por: Kim, Bun, et al.
Publicado: (2016)

Efficacy and safety of Gelidium elegans intake on bowel symptoms in obese adults: A 12-week randomized double-blind placebo-controlled trial
por: Choi, Hyoung Il, et al.
Publicado: (2019)

Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study
por: Kim, Eun Hye, et al.
Publicado: (2015)

Use of device-assisted enteroscopy in small bowel disease: an expert consensus statement by the Korean Association for the Study of Intestinal Diseases
por: Lee, Han Hee, et al.
Publicado: (2023)

Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future
por: Lee, Jung Won, et al.
Publicado: (2015)

Interleukin-33 and Mast Cells Bridge Innate and Adaptive Immunity: From the Allergologist’s Perspective
por: Jang, Tae Young, et al.
Publicado: (2015)

Needle Knife-assisted Endoscopic Polypectomy for a Large Inflammatory Fibroid Colon Polyp by Making Its Stalk into an Omega Shape Using an Endoloop
por: Kim, Byung Chang, et al.
Publicado: (2008)

Exogenous Interleukin-33 Contributes to Protective Immunity via Cytotoxic T-Cell Priming against Mucosal Influenza Viral Infection
por: Kim, Chae Won, et al.
Publicado: (2019)

The Relationship between Small-Intestinal Bacterial Overgrowth and Intestinal Permeability in Patients with Irritable Bowel Syndrome
por: Park, Jung Ho, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_99mii6en77l3dk0p4348i5l026